• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用干法分散激光衍射评估球形团聚体配方中的分散性。

Using Dry Dispersion Laser Diffraction to Assess Dispersibility in Spheronized Agglomerate Formulations.

机构信息

Merck & Co., Inc., Sterile and Specialty Products, Rahway, New Jersey, USA.

Merck & Co., Inc., Small Molecule Analytical Research and Development, Rahway, New Jersey, USA.

出版信息

AAPS PharmSciTech. 2024 Feb 23;25(3):45. doi: 10.1208/s12249-024-02743-8.

DOI:10.1208/s12249-024-02743-8
PMID:38396188
Abstract

In this study, dry dispersion laser diffraction was used to study the dispersibility of spheronized agglomerate formulations and identify geometric particle size metrics that correlated well with aerodynamic particle size distribution (APSD). Eleven unique batches of agglomerates were prepared for both laser diffraction and cascade impaction testing. Correlations between the particle size distribution (PSD) and aerodynamic particle size distribution (APSD) metrics for the eleven agglomerate batches were determined in a semi-empirical manner. The strongest correlation between APSD and PSD was observed between the impactor-sized mass (%ISM) and the cumulative PSD fraction <14.5 µm. The strongest correlation with fine particle fraction (FPF) was observed with the cumulative PSD fraction <0.99 micron (R-squared = 0.974). In contrast to the other APSD metrics, good correlations were not found between the mass median aerodynamic diameter (MMAD) and the cumulative PSD fractions. Overall, the implementation of laser diffraction as a surrogate for cascade impaction has the potential to streamline product development. Laser diffraction measurements offer savings in labor and turnaround time compared to cascade impaction.

摘要

在这项研究中,干分散激光衍射被用于研究球形团聚体配方的分散性,并确定与空气动力学粒径分布(APSD)相关性良好的几何粒径指标。为激光衍射和级联撞击测试制备了十一个独特的团聚体批次。以半经验的方式确定了十一个团聚体批次的粒径分布(PSD)和空气动力学粒径分布(APSD)指标之间的相关性。在 APSD 和 PSD 之间观察到最强的相关性是在冲击器大小的质量(%ISM)和累积 PSD 分数<14.5 µm 之间。与细颗粒分数(FPF)的最强相关性是在累积 PSD 分数<0.99 微米(R-squared = 0.974)处观察到的。与其他 APSD 指标相反,在质量中值空气动力学直径(MMAD)和累积 PSD 分数之间未发现良好的相关性。总体而言,将激光衍射作为级联撞击的替代方法具有简化产品开发的潜力。与级联撞击相比,激光衍射测量在劳动力和周转时间方面具有节省成本的优势。

相似文献

1
Using Dry Dispersion Laser Diffraction to Assess Dispersibility in Spheronized Agglomerate Formulations.采用干法分散激光衍射评估球形团聚体配方中的分散性。
AAPS PharmSciTech. 2024 Feb 23;25(3):45. doi: 10.1208/s12249-024-02743-8.
2
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.用于测定雾化粉末制剂粒度的激光衍射方法的开发。
Int J Pharm. 2006 Dec 1;326(1-2):39-49. doi: 10.1016/j.ijpharm.2006.07.021. Epub 2006 Jul 16.
3
Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations.基于载体的雾化干粉制剂的惯性碰撞与激光衍射粒度分析数据之间的相关性。
Pharm Res. 2006 Sep;23(9):2200-9. doi: 10.1007/s11095-006-9055-9. Epub 2006 Aug 10.
4
Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.丙酸氟替卡松在干粉吸入剂制剂中的聚集行为。
Eur J Pharm Biopharm. 2012 Apr;80(3):596-603. doi: 10.1016/j.ejpb.2011.12.004. Epub 2011 Dec 14.
5
Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffraction.使用惯性撞击和激光衍射对无载体干粉气雾剂配方进行表征。
Pharm Res. 2006 Sep;23(9):2210-9. doi: 10.1007/s11095-006-9056-8. Epub 2006 Aug 10.
6
Novel dry powder inhalation system based on dispersion of lyophilisates.基于冻干制剂分散的新型干粉吸入系统。
Eur J Pharm Sci. 2011 May 18;43(1-2):32-40. doi: 10.1016/j.ejps.2011.03.005. Epub 2011 Mar 31.
7
Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations.用于测定雾化粉末制剂粒度的级联撞击器分析与激光衍射技术之间的相关性。
Int J Pharm. 2008 Jun 24;358(1-2):75-81. doi: 10.1016/j.ijpharm.2008.02.014. Epub 2008 Feb 17.
8
Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical Programs.多阶段级联撞击器测定被动干粉吸入器空气动力学粒径分布:国际药品气溶胶联合会监管与科学(IPAC-RS)建议,以支持产品质量控制和临床项目。
AAPS PharmSciTech. 2019 May 30;20(5):206. doi: 10.1208/s12249-019-1416-x.
9
Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.单独药物和基于载体的 GLP-1 干粉吸入剂制剂的开发。
Int J Pharm. 2022 Apr 5;617:121601. doi: 10.1016/j.ijpharm.2022.121601. Epub 2022 Feb 16.
10
Measurement of Aerodynamic Particle Size Distribution of Orally Inhaled Products by Cascade Impactor: How to Let the Product Specification Drive the Quality Requirements of the Cascade Impactor.通过级联撞击器测量口服吸入产品的空气动力学粒径分布:如何让产品规格驱动级联撞击器的质量要求。
AAPS PharmSciTech. 2019 Jan 8;20(2):57. doi: 10.1208/s12249-018-1276-9.

本文引用的文献

1
The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates.干粉吸入器的困惑世界:关键在于吸气压力,而非吸气流速。
J Aerosol Med Pulm Drug Deliv. 2020 Feb;33(1):1-11. doi: 10.1089/jamp.2019.1556. Epub 2019 Oct 31.
2
Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?理想吸入器与现实吸入器:是否有可能绕过在上呼吸道的沉积?
J Aerosol Med Pulm Drug Deliv. 2019 Apr;32(2):55-69. doi: 10.1089/jamp.2018.1497. Epub 2018 Dec 6.
3
Comparison of optical particle sizing and cascade impaction for measuring the particle size of a suspension metered dose inhaler.
用于测量混悬型定量吸入器颗粒大小的光学颗粒筛分法与级联冲击法的比较
Drug Dev Ind Pharm. 2015 May;41(5):737-43. doi: 10.3109/03639045.2014.900079. Epub 2014 Mar 19.
4
Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction.使用干法分散激光衍射快速表征可吸入粉末的固有分散性。
Int J Pharm. 2013 Apr 15;447(1-2):124-31. doi: 10.1016/j.ijpharm.2013.02.034. Epub 2013 Feb 19.
5
Product lifecycle approach to cascade impaction measurements.产品生命周期方法在级联撞击测量中的应用。
AAPS PharmSciTech. 2011 Mar;12(1):312-22. doi: 10.1208/s12249-011-9590-5. Epub 2011 Feb 1.
6
Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs).提高口吸入药物产品(OIPs)级联撞击测量的质量控制指标。
AAPS PharmSciTech. 2009;10(4):1276-85. doi: 10.1208/s12249-009-9312-4. Epub 2009 Oct 29.
7
Surface energy changes and their relationship with the dispersibility of salmeterol xinafoate powders for inhalation after storage at high RH.表面能变化及其与沙美特罗替卡松干粉在高相对湿度下储存后分散性的关系。
Eur J Pharm Sci. 2009 Nov 5;38(4):347-54. doi: 10.1016/j.ejps.2009.08.007. Epub 2009 Sep 2.
8
In vitro/in vivo comparisons in pulmonary drug delivery.肺部药物递送的体外/体内比较。
J Aerosol Med Pulm Drug Deliv. 2008 Mar;21(1):77-84. doi: 10.1089/jamp.2007.0643.
9
Particle engineering for pulmonary drug delivery.用于肺部给药的颗粒工程。
Pharm Res. 2007 Mar;24(3):411-37. doi: 10.1007/s11095-006-9174-3.
10
Inhaling medicines: delivering drugs to the body through the lungs.吸入药物:通过肺部将药物输送到体内。
Nat Rev Drug Discov. 2007 Jan;6(1):67-74. doi: 10.1038/nrd2153.